Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain From Bunionectomy. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Tapentadol for acute pain after bunionectomy has completed, with results posted in 2010. The sponsor is Johnson & Johnson Pharmaceutica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hallux Valgus
• Pain
• Postoperative Pain

Drugs mentioned

• Tapentadol (Nucynta) (tapentadol)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Arthralgia, Bunion | Phase 3 | Status: COMPLETED | Results posted: 2010-04-23